54 results
Page 2 of 3
6-K
EX-99.1
lye17n
15 Feb 22
Current report (foreign)
4:27pm
424B5
e39t15z
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.2
oa14un128o ip
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
rws518h6448s 3ncyzz
8 Jul 21
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
4:05pm
424B8
uxt85
19 Apr 21
Prospectus unintentially filed late
5:06pm
424B5
62jr8ox
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
mt1rt2v0o32910n
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
jd5k53p6706
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
a509uozsw own0brgux
30 Dec 20
Shelf registration (foreign)
4:17pm
424B5
g68ff lgmsrlshum
12 May 20
Prospectus supplement for primary offering
12:02pm
424B5
158t7g
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
EX-99.2
w5in 5b6y7
1 Nov 19
Current report (foreign)
4:15pm
424B5
wrfe9j9imopew
17 May 19
Prospectus supplement for primary offering
5:19pm